| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| GP4-V15223 | HIV | HIV-1 [HIV-1/Clade E (CM244)] GP120 Protein, His Tag |  |
|
|
| GP5-V15224 | HIV | HIV-1 [HIV-1/Clade C (16055)] GP120 Protein, His Tag |  |
|
|
Immobilized Human CD4, Fc Tag (Cat. No. CD4-H5259) at 2 μg/mL (100 μL/well) can bind HIV-1 [HIV-1/Clade C (16055)] GP120, His Tag (Cat. No. GP5-V15224) with a linear range of 0.5-63 ng/mL (QC tested).
Immobilized Human CD4, Fc Tag (Cat. No. CD4-H5259) at 5 μg/mL (100 μL/well) can bind HIV-1 [HIV-1/Clade E (CM244)] GP120, His Tag (Cat. No. GP4-V15223) with a linear range of 20-156 ng/mL (QC tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Radha-108 | Approved | Biomix Network | Receptol | HIV Infections | Details | |||||
| Fostemsavir Tromethamine | 97IQ273H4L (UNII code); GSK 3684934; BMS-663068-03; BMS 626529 prodrug; BMS-663068; GSK-3684934A | Approved | Bristol-Myers Squibb Company | Rukobia | EU | HIV Infections | Viiv Healthcare Bv | 2020-07-02 | HIV Infections | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Microbicide monoclonal antibody triple combination (Polymun Scientific Immunobiologische Forschung) | Phase 1 Clinical | Polymun Scientific | HIV Infections | Details | |
| Elipovimab | GS-9722 | Phase 1 Clinical | Gilead | HIV Infections | Details |
| PDPHV-201401 | PDPHV-201401 | Phase 1 Clinical | National Institute Of Allergy And Infectious Diseases (Niaid) | HIV Infections | Details |
| Suvizumab | KD-247 | Phase 1 Clinical | Kaketsuken | HIV Infections | Details |
| A-1801 | A-1801 | Clinical | Wuhan Bio-Raid Biotechnology | HIV Infections | Details |
| 3BNC-117 | GS-5423; 3BNC117-LS; 3BNC117 | Phase 2 Clinical | The Rockefeller University | HIV Infections; Acquired Immunodeficiency Syndrome | Details |
| GS-2872 | 10-1074; 10-1074-LS; GS-2872 | Phase 2 Clinical | The Rockefeller University | HIV Infections | Details |
This web search service is supported by Google Inc.
A-Z
